A therapeutic approach to érythrodermie psoriasis: Report of a case and a discussion of therapeutic options
Van der Vleuten CJM. Gerritsen MJP, Steijlen PM. de Jong EMGJ. van de Kerkhof PCM: A therapeutic approach to érythrodermie psoriasis: Report of a case and a discussion of therapeutic options. Acta Derm Venereol (Stockh) 1996;76:65-67.
Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis
Larsen FG: Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis. Acta Derm Venereol (Stockh) 1994:74 (suppl 190).
A multicentre 12-week open study of a lipid-soluble folate-antagonist, piritrexim in severe psoriasis
Perkins W. Williams REA. Vestey JP. Tidman HJ. Layton AM. Cunliffe WJ, Saihan EM. Klabcr MR. Manna VK. Baker H, Mackie RM: A multicentre 12-week open study of a lipid-soluble folate-antagonist, piritrexim in severe psoriasis. Br J Dermatol 1993:129:584-589.
The effects of retinoids and lerbinafine on the human microsomal metabolism of cyclosporin
Shah IA. Whiting PH. Omar G. Ormerod AK. Burke MD: The effects of retinoids and lerbinafine on the human microsomal metabolism of cyclosporin. Br J Dermatol 1993;129:395-398.
Combination therapy ciclosporin-etretinatc effective in érythrodermie psoriasis (Letter)
Korstanje MJ. Bessems PJMJ, van de Slaak WJBM: Combination therapy ciclosporin-etretinatc effective in érythrodermie psoriasis (letter). Dermatologien 1989:179:94.
Acitretin does not prevent psoriasis relapse related to cyclosporin A tapering
Salomon D. Mesheit J. Masgrau-Peya E, Feldmann R. Saurai JH: Acitretin does not prevent psoriasis relapse related to cyclosporin A tapering. Br J Dermatol 1994; 130:257-258.
Combination of etretinate with cyclosporin A in the treatment of severe recalcitrant psoriasis
Brechtel B. Wcllenreuther U, Toppe E, Czametzki BM: Combination of etretinate with cyclosporin A in the treatment of severe recalcitrant psoriasis. J Am Acad Dermatol 1994:30:1023-1024